These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hirudin: initial results in acute myocardial infarction, unstable angina and angioplasty. Cannon CP; Braunwald E J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):30S-37S. PubMed ID: 7775712 [TBL] [Abstract][Full Text] [Related]
3. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes. Haas S Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477 [TBL] [Abstract][Full Text] [Related]
4. [Hirudin is superior to heparin in reducing cardiovascular mortality, infarct and refractory angina in patients with unstable angina or myocardial infarct without elevation of the ST tract]. Franzosi MG Ital Heart J Suppl; 2000 Sep; 1(9):1210-2. PubMed ID: 11140295 [No Abstract] [Full Text] [Related]
5. GUSTO II trial. Aylward P Aust N Z J Med; 1993 Dec; 23(6):766-8. PubMed ID: 8141723 [TBL] [Abstract][Full Text] [Related]
6. [The importance of thrombin and its inhibition in unstable angina. Nonfractionated heparin, hirudin and defractionated heparins]. López-Sendón J; López de Sá E; Rubio Sanz R; Delcán Domínguez JL Rev Esp Cardiol; 1999; 52 Suppl 1():76-89. PubMed ID: 10364817 [TBL] [Abstract][Full Text] [Related]
7. Hirudin in the treatment of arterial and venous thrombotic diseases: a new perspective. Büller HR Z Kardiol; 1993; 82 Suppl 2():81-2. PubMed ID: 8328213 [TBL] [Abstract][Full Text] [Related]
8. [Current point of view on medical treatment of unstable angina]. Col J Arch Mal Coeur Vaiss; 1996 Oct; 89 Spec No 5():15-8. PubMed ID: 8952815 [TBL] [Abstract][Full Text] [Related]
9. Treatment options in unstable angina: a clinical update. Fox KA; Antman EM Eur Heart J; 1998 Sep; 19 Suppl K():K8-10. PubMed ID: 9790283 [TBL] [Abstract][Full Text] [Related]
10. Approaches to the treatment of unstable angina and non-Q wave myocardial infarction. Cohen M Can J Cardiol; 1998 Aug; 14 Suppl E():11E-14E. PubMed ID: 9779027 [TBL] [Abstract][Full Text] [Related]
12. Specific antithrombins in the context of current treatment for acute coronary syndromes. Fox KA Eur Heart J; 1999 Nov; 20(21):1519-21. PubMed ID: 10529315 [No Abstract] [Full Text] [Related]
13. [Heparin, low-molecular-weight heparin and their clinical use]. Neri Serneri GG Ann Ital Med Int; 1993; 8(2):69-72. PubMed ID: 8394728 [TBL] [Abstract][Full Text] [Related]
14. Hirudin in acute coronary syndromes. van de Loo A; Bode C Semin Thromb Hemost; 2002 Oct; 28(5):459-66. PubMed ID: 12420242 [TBL] [Abstract][Full Text] [Related]
17. Anticoagulants in coronary artery disease. Lee LV Cardiol Clin; 2008 Nov; 26(4):615-28. PubMed ID: 18929235 [TBL] [Abstract][Full Text] [Related]
18. Current roles and future possibilities for low-molecular-weight heparins in unstable angina. Purcell H; Fox KM Eur Heart J; 1998 Sep; 19 Suppl K():K18-23. PubMed ID: 9790285 [TBL] [Abstract][Full Text] [Related]
19. Thrombolytic therapy and percutaneous coronary intervention in unstable angina. Ambrose JA; Coppola JT Semin Interv Cardiol; 2000 Sep; 5(3):129-35. PubMed ID: 11054910 [No Abstract] [Full Text] [Related]
20. [Advantages and disadvantages of thrombolytic therapy of unstable angina pectoris]. Qian X; Hu D; Jia G; Wu Z Zhonghua Nei Ke Za Zhi; 1997 Jun; 36(6):365-7. PubMed ID: 10374292 [No Abstract] [Full Text] [Related] [Next] [New Search]